SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,793,401 | -12.7% | 65,049 | -4.8% | 0.00% | 0.0% |
| Q2 2023 | $2,054,120 | +5.3% | 68,334 | +26.9% | 0.00% | 0.0% |
| Q1 2023 | $1,950,206 | -1.3% | 53,829 | -2.8% | 0.00% | 0.0% |
| Q4 2022 | $1,976,225 | +7.1% | 55,403 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $1,846,000 | +8.8% | 55,478 | -6.7% | 0.00% | 0.0% |
| Q2 2022 | $1,696,000 | -13.1% | 59,449 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $1,951,000 | -22.2% | 60,340 | -29.7% | 0.00% | 0.0% |
| Q4 2021 | $2,508,000 | -48.7% | 85,827 | -52.1% | 0.00% | -57.1% |
| Q3 2021 | $4,888,000 | +51.1% | 179,247 | +70.6% | 0.01% | +75.0% |
| Q2 2021 | $3,235,000 | +34.1% | 105,047 | +14.1% | 0.00% | 0.0% |
| Q1 2021 | $2,412,000 | -81.4% | 92,095 | -82.1% | 0.00% | -81.8% |
| Q4 2020 | $12,944,000 | -4.8% | 514,453 | -21.1% | 0.02% | -12.0% |
| Q3 2020 | $13,593,000 | -7.4% | 652,222 | +5.6% | 0.02% | -10.7% |
| Q2 2020 | $14,674,000 | +110.6% | 617,856 | +59.5% | 0.03% | +86.7% |
| Q1 2020 | $6,967,000 | -44.9% | 387,260 | -27.3% | 0.02% | -21.1% |
| Q4 2019 | $12,639,000 | +45.8% | 532,831 | +68.9% | 0.02% | +35.7% |
| Q3 2019 | $8,668,000 | +195.3% | 315,423 | +255.7% | 0.01% | +180.0% |
| Q2 2019 | $2,935,000 | -33.2% | 88,679 | -29.3% | 0.01% | -28.6% |
| Q1 2019 | $4,396,000 | +6.8% | 125,452 | +1.2% | 0.01% | 0.0% |
| Q4 2018 | $4,118,000 | -35.1% | 123,950 | -1.6% | 0.01% | -22.2% |
| Q3 2018 | $6,344,000 | -75.3% | 126,000 | -70.6% | 0.01% | -76.3% |
| Q2 2018 | $25,643,000 | +39.8% | 428,458 | +7.0% | 0.04% | +35.7% |
| Q1 2018 | $18,346,000 | +16.0% | 400,578 | +1.0% | 0.03% | +27.3% |
| Q4 2017 | $15,817,000 | -2.4% | 396,745 | -2.0% | 0.02% | -4.3% |
| Q3 2017 | $16,199,000 | -14.0% | 404,970 | -7.4% | 0.02% | -17.9% |
| Q2 2017 | $18,841,000 | +167.3% | 437,140 | +94.1% | 0.03% | +154.5% |
| Q1 2017 | $7,048,000 | +2.0% | 225,190 | -17.7% | 0.01% | 0.0% |
| Q4 2016 | $6,909,000 | +9.6% | 273,599 | +7.3% | 0.01% | +10.0% |
| Q3 2016 | $6,305,000 | +56.6% | 254,946 | +29.0% | 0.01% | +42.9% |
| Q2 2016 | $4,026,000 | +182.3% | 197,656 | +111.4% | 0.01% | +133.3% |
| Q1 2016 | $1,426,000 | -10.1% | 93,516 | -20.8% | 0.00% | 0.0% |
| Q4 2015 | $1,587,000 | -1.4% | 118,108 | +3.0% | 0.00% | 0.0% |
| Q3 2015 | $1,609,000 | -47.0% | 114,651 | -35.8% | 0.00% | -40.0% |
| Q2 2015 | $3,034,000 | +1832.5% | 178,651 | +1274.2% | 0.01% | – |
| Q1 2015 | $157,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |